Deerfield Management Company, L.P. 13D and 13G filings for Xilio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-29 5:24 pm Sale | 2022-12-29 | 13G | XILIO THERAPEUTICS INC XLO | Deerfield Management Company, L.P. | 0 0.000% | -153,861 (Position Closed) | Filing |
| 2022-02-11 4:14 pm Sale | 2021-12-31 | 13G | XILIO THERAPEUTICS INC XLO | Deerfield Management Company, L.P. | 153,861 7.840% | -9,564 (-5.85%) | Filing |
| 2021-10-26 7:35 pm Purchase | 2021-10-26 | 13G | XILIO THERAPEUTICS INC XLO | Deerfield Management Company, L.P. | 163,425 8.580% | 163,425 (New Position) | Filing |